Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cerebral vasodilatory capacity map, consisting of a 99mTc-DTPA-
HSA
SPECT image obtained after acetazolamide injection minus the baseline image, was produced in a patient with moyamoya disease. The map demonstrated diminished capacity in the posterior region of the right cerebral hemisphere. Subsequently,
cerebral infarction
occurred in the corresponding area. This observation suggests that regions of low vasodilatory capacity identified by cerebral vasodilatory capacity mapping may be at high risk of ischemic stroke.
...
PMID:Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease. 822 45
Cerebral blood volume measurement by Tc-99m-DTPA-
HSA
SPECT was performed in a patient with subacute
cerebral infarction
to evaluate compensatory vasodilatation. Additional delayed imaging revealed focal increased radioactivity that was not found on the early images, indicating leakage of radioactive agents due to blood-brain barrier breakdown. Delayed SPECT may be helpful to detect areas unsuitable for estimating regional blood volume.
...
PMID:Delayed imaging of Tc-99m-DTPA-HSA SPECT in subacute cerebral infarction. 829 Jun 99